Molecular Diagnostics at the Point of Care

 "Molecular Diagnostics at the Point of Care.  By Application, Technology, Place, Product and by Country.  With Executive Guides and Customization 2023 - 2027" has the answers. 

435 pages packed with information.

Infectious disease Dx is changing and will change more in the future.  Can a rapidly growing market expand even faster?  Find out all about it in this comprehensive report on Molecular Diagnostics at the Point of Care.

Are targeted tests for specific pathogens going to be obsolete?  Will diagnostics replace physicians?  Will Point of Care testing move into the Physician’s Office or even the Home? 

Point of Care testing is proving itself in the market. Players are reporting double digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance.  Learn about this market including the issues and outlooks.  The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.  It could possibly displace most frontline test protocols AND save money at the same time.  The report forecasts the market size out for five years. 

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report.  Your credit card order sends the report to your inbox instantly.  Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges. 

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.  

View the Table of Contents.

Send an email to us at service@howesoundresearch.com and we will happily email you a FREE copy of SAMPLE PAGES FROM THIS REPORT without any obligation on your part. 

 ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. 

He is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

B.Sc. (Chemistry) University of BC

M.B.A. (Finance and Policy) University of BC

Market Research - Burke Institute

Finance for Senior Executives - Harvard Business School